These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 20415167

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Control of persistent asthma in Spain: associated factors.
    Díez Jde M, Barcina C, Muñoz M, Leal M.
    J Asthma; 2008 Nov; 45(9):740-6. PubMed ID: 18972288
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Disease impact and patient insight--a study on a local population of asthmatics.
    Ahmad NS, Chan MY, Hiew FL, Sharif SA, Vijayasingham P, Thayaparan T, Loh LC.
    Med J Malaysia; 2003 Oct; 58(4):526-32. PubMed ID: 15190628
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of omalizumab in an Asian population with moderate-to-severe persistent asthma.
    Ohta K, Miyamoto T, Amagasaki T, Yamamoto M, 1304 Study Group.
    Respirology; 2009 Nov; 14(8):1156-65. PubMed ID: 19909462
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of 3-5 months' add-on therapy with montelukast in patients with non-controlled asthma in Austria: the STAR open-label, real-world, observational study.
    Schlick W, Pohl W, Pfeiffer KP, Aigner K, Forche G, Kneussl M, Zwick H.
    Curr Med Res Opin; 2010 Mar; 26(3):561-70. PubMed ID: 20050815
    [Abstract] [Full Text] [Related]

  • 11. Ratio of controller to total asthma medications: determinants of the measure.
    Broder MS, Gutierrez B, Chang E, Meddis D, Schatz M.
    Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
    [Abstract] [Full Text] [Related]

  • 12. Evidence for benefits of early intervention with non-steroidal drugs in asthma.
    König P.
    Pediatr Pulmonol Suppl; 1997 Sep; 15():34-9. PubMed ID: 9316100
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE study.
    Sthoeger ZM, Eliraz A, Asher I, Berkman N, Elbirt D.
    Isr Med Assoc J; 2007 Jun; 9(6):472-5. PubMed ID: 17642399
    [Abstract] [Full Text] [Related]

  • 17. [Factors influencing asthma course and the degree of control in the patients assessed with own questionnaire and Asthma Control Test (ACT)].
    Krasnodębska P, Hermanowicz-Salamon J, Domagała-Kulawik J, Chazan R.
    Pneumonol Alergol Pol; 2012 Jun; 80(3):198-208. PubMed ID: 22562271
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U, Dass SB.
    Clin Ther; 2008 Jun; 30 Spec No():1026-35. PubMed ID: 18640477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.